INNOVIVA, INC. Operating Leases, Future Minimum Payments, Due in Three Years
INNOVIVA, INC. (INVA) had Operating Leases, Future Minimum Payments, Due in Three Years of $428.00 thousand as of 2018-12-31, per its 10-K filed 2019-02-19.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears · last filed 2019-02-19
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $428.00K.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $416.00K.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $403.00K.
- 2011-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $4.86M.
| Period end | Operating Leases, Future Minimum Payments, Due in Three Years |
|---|---|
| 2018-12-31 | $428.00K 10-K · filed 2019-02-19 |
| 2017-12-31 | $416.00K 10-K · filed 2018-02-23 |
| 2016-12-31 | $403.00K 10-K · filed 2017-02-28 |
| 2011-12-31 | $4.86M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |